Parse

Parse indexes AI recommendations so brands know where they stand.

Products

  • Brands
  • Markets
  • Integrations
  • Work with us
  • Pricing
  • MCP

Resources

  • Research
  • Methodology
  • Blog

© 2026 Parse. All rights reserved.

LegalPrivacy PolicyTerms of Service
Parse
Work with usPricing
Sign inCheck your brand
  1. Brands
  2. Guardant Health
BrandsGuardant Health

How AI describes Guardant Health

Data as of Aug 25, 2026 · Based on 3,181,687 AI responses across 10,525 prompts · See how Parse measures this

Guardant Health logoGuardant Healthguardanthealth.com · Low evidence

Parse Score

39.9
Strength3/ 100
Reach14/ 100
Authority31/ 100

Work at Guardant Health?

Claim this profile for the full report: every prompt where Guardant Health appears, who is gaining, and what AI says about you. Claiming is free. Ongoing monitoring is a paid upgrade.

Verified with a work email.

Sources

guardanthealth.com shapes more of what AI says about Guardant Health than any other source, at 14% of its citations.

medicalstartups.org · moneyweek.com · google.com · grandviewresearch.com

AI questions where Guardant Health appears

  • Excerpts where Guardant Health appeared in the AI's answer

    Google AI Mode · excerpt
    Guardant Health (Shield) : FDA-approved for blood-based colorectal cancer screening
    Google AI Mode · excerpt
    Guardant Health (Guardant360): An AI-powered liquid biopsy test that analyzes tumor DNA in blood to identify colorectal cancer mutations.
  • Excerpts where Guardant Health appeared in the AI's answer

    ChatGPT Search · excerpt
    Guardant Health — liquid biopsy tests that help select targeted therapies and monitor response.
    Google AI Mode · excerpt
    Guardant Health : Focuses on advanced blood and tissue tests (ctDNA) to detect cancer early and provide insights into the molecular drivers of the disease.
  • Excerpts where Guardant Health appeared in the AI's answer

    Google AI Mode · excerpt
    Guardant Health: Specializes in using AI for liquid biopsy and genomic testing to guide cancer therapy decisions.